Gene · 4900
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study. | Lancet Neurol | 2026 | 42785333 | PubTator, text mining | PubMed |
| Proteomic markers linking anxiety phenotypes to Alzheimer's disease risk: a multi-analyte proteomic analysis. | medRxiv | 2026 | 42779925 | PubTator, text mining | PubMed |
| Altered synaptic and astrocytic proteins in Lewy body disorders associated with GBA mutations. | Brain Commun | 2026 | 42582587 | PubTator, text mining | PubMed |
| Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities. | Mol Biol Rep | 2026 | 42573665 | PubTator, text mining | PubMed |
| Harnessing Affinity Tags for Recombinant Protein Purification: Concepts, Methods, and Troubleshooting. | Methods Mol Biol | 2026 | 42562985 | PubTator, text mining | PubMed |
| Biochemical modulators of synaptic plasticity: New horizons in Alzheimer's disease treatment. | J Alzheimers Dis | 2026 | 42489531 | PubTator, text mining | PubMed |
| NRGN inhibits CD8⁺ T cell effector function by downregulating MHC-I expression through the FMR1-IRF8 axis in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2026 | 42458540 | PubTator, text mining | PubMed |
| Higher physical activity levels mitigate synaptic protein loss and cognitive deterioration in aging and in Alzheimer's disease: a 10-year longitudinal study. | Mol Biomed | 2026 | 42455424 | PubTator, text mining | PubMed |
| Glial molecular signatures as a liquid biopsy marker in Alzheimer's disease diagnosis. | Int Rev Neurobiol | 2026 | 42442917 | PubTator, text mining | PubMed |
| Value of synaptic proteins as biomarkers in amyotrophic lateral sclerosis. | Brain Commun | 2026 | 42404435 | PubTator, text mining | PubMed |
| SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer's disease. | Nat Commun | 2026 | 42331820 | PubTator, text mining | PubMed |
| Longitudinal Alterations in Sleep EEG Biomarkers of Memory Consolidation in Middle-Aged and Older Adults. | bioRxiv | 2026 | 42182430 | PubTator, text mining | PubMed |
| Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment. | Biomolecules | 2026 | 42072639 | PubTator, text mining | PubMed |
| Age-Specific Clinical Biomarker Ranges in Acute Head Injury, Non-TBI Trauma, and Healthy Control Subjects in the Emergency Department. | Acad Emerg Med | 2026 | 42048067 | PubTator, text mining | PubMed |
| Neurogranin Promotes Neuronal Maturation and Network Activity Through Ca2+/Calmodulin Signaling. | Int J Mol Sci | 2026 | 41977485 | PubTator, text mining | PubMed |
| Cognition in multiple sclerosis. | Curr Opin Neurol | 2026 | 41960777 | PubTator, text mining | PubMed |
| Single-nucleus transcriptomics identifies a shared vulnerable excitatory neuronal population across typical and atypical Alzheimer's disease. | bioRxiv | 2026 | 41959086 | PubTator, text mining | PubMed |
| Misfolded Proteins and Cognitive Decline: Mechanistic Insights into Neurodegenerative Disorders. | Neurol Int | 2026 | 41893050 | PubTator, text mining | PubMed |
| Multiple sclerosis synaptic connectome: Insights from fluid biomarkers. | Neural Regen Res | 2026 | 41837521 | PubTator, text mining | PubMed |
| Association between spirochaetal infection and neurodegenerative diseases: a systematic review and quantitative synthesis of observational studies. | J Med Microbiol | 2026 | 41790564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4900/papers